美国耐药感染在NDM基因细菌的推动下,从2019年上升近70%至2023年,构成日益严重的公共健康威胁。 U.S. drug-resistant infections, fueled by NDM gene bacteria, rose nearly 70% from 2019 to 2023, posing a growing public health threat.

美国抗药性“噩梦细菌”感染从2019年上升近70%至2023年, 主要是由携带NDM基因的细菌驱动, 这些细菌抗大部分抗生素, 需要昂贵的IV治疗。 Drug-resistant "nightmare bacteria" infections in the U.S. have risen nearly 70% from 2019 to 2023, driven largely by bacteria carrying the NDM gene, which resist most antibiotics and require expensive IV treatments. 疾病预防控制中心报告称，碳青霉烯类耐药感染急剧增加，NDM 病例增加了五倍多，尽管由于检测和报告不完整，实际数字可能更高，尤其是在主要州。 The CDC reports a sharp increase in carbapenem-resistant infections, with NDM cases rising more than fivefold, though actual numbers are likely higher due to incomplete testing and reporting, especially in major states. 专家将这种激增与这一大流行病期间广泛使用抗生素联系起来,并警告未被发现的载体能够促进社区传播。 Experts link the surge to widespread antibiotic use during the pandemic and warn of undetected carriers enabling community spread. 调查结果突显了日益严重的公共卫生威胁,强调迫切需要加强监测、感染控制和抗生素管理。 The findings highlight a growing public health threat, underscoring the urgent need for better surveillance, infection control, and antibiotic stewardship.